A big thank you to Mirja Tenhunen and other organizers for two great Clinical Neurophysiology Days in Tampere! Nice to see so many familiar faces and demo our NBS 6 to an interested audience! #knf #knfpaivat2024 #neurofys #brainmapping #clinicalneurophysiology
Nexstim
Medical Equipment Manufacturing
We enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
About us
Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain. In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on Nasdaq First North Growth Market Finland.
- Sivusto
-
http://www.nexstim.com
External link for Nexstim
- Toimiala
- Medical Equipment Manufacturing
- Yrityksen koko
- 11–50 työntekijää
- Päätoimipaikka
- Helsinki
- Tyyppi
- Public Company
- Perustettu
- 2000
- Erityisosaaminen
Sijainnit
-
Ensisijainen
Elimäenkatu 9 B
Helsinki, FI-00510, FI
Työntekijät Nexstim
Päivitykset
-
Come say hello to us at the Clinical Neurophysiology Days | KNF-päivät in Tampere, Finland! We are running live demonstrations and are excited to show our Finnish user community and those interested in nTMS what is new and coming up! #knf #knfpaivat2024 #neurofys #nTMS #tms #tmstherapy #neurophysiology
-
Nexstim julkaisi tämän uudelleen
Positive 52-week Alzheimer's data presented today at #CTAD2024: Our personalized #neuromodulation therapy met primary and key secondary endpoints including CDR-SB, ADAS- Cog11 and NPI, showing strong separation from placebo and statistical significance in mild-to-moderate patients, with no serious side-effects. The treatment slowed Alzheimer’s in all 3 clinically measured domains: cognition, function, and behavior, and on one key functional measure, Activities of Daily Living (ADCS-ADL), Alzheimer’s disease patients receiving treatment were nearly unchanged after one year. #neurotech #innovation #MedTech #AlzMoonshot #ENDALZ https://lnkd.in/eGqZRJE2
-
Women in neurotech representing strong at this year’s nTMS Symposium! It’s been a couple weeks since, but we want to take a moment to honor the amazing achievements of the abstract winners! From a pool of nearly 40 submissions, the participants selected the following abstracts: 🏆 Winner: Melina Engelhardt - Reduced reactivity in peritumoral tissue as measured by TMS-EEG 🥈 1st Runner Up: Anna Nätkynmäki - Spinally targeted paired associated stimulation with high-frequency peripheral component induces spinal level plasticity in healthy subjects 🥉 2nd Runners Up: Josephine Jung - Functional Cortical Mapping and Structural Subcortical Anatomy predicts Intra-Operative Speech Arrest: a nTMS-Tractography Study Leonie Kram - Integration of complex and language profile-specific tasks to identify highly interlinked language and cognitive network components in glioma patients Chrisa Fotiadou - The effects of repetitive Transcranial Magnetic Stimulation on language performance and changes in brain connectivity in healthy individuals We celebrate these outstanding women for their innovative contributions to the field of non-invasive brain stimulation, well done! 👏 Read more about the symposium here: https://lnkd.in/eEWXbDyZ and sign up here to be notified, when we publish some select talks later on our Nexstim Podium page: https://lnkd.in/eRtBkgB4 #nTMSSymposium #WomenInScience #Neuroscience #AbstractWinners #InnovationInResearch #brainmapping #nTMS
-
Nexstim julkaisi tämän uudelleen
Mapping the brain during surgery is a standard of care, though techniques and philosophies are wildly variable. Mapping the brain via nTMS prior to surgery represents a significant opportunity for risk stratification, but also provides insight regarding interhemispheric reorganisation, cortical excitability changes, and the prospect of therapeutic neuromodulation for rehabilitation. Please join Neuroclast and Brainlab for the Navigated TMS & Fibretracking for Resection Planning Workshop during Controversies in Neurosurgery hosted by Kate Drummond AM and the The Royal Melbourne Hospital: 📅 November 14, 2024 🕒 4 to 6 PM 📍The Langham Hotel, Melbourne, Australia Register here: https://lnkd.in/gYR6xuF5 The workshop will be a combination of expert insights, Nexstim live demos and interactive Brainlab Elements planning stations with speakers: > Peter Vajkoczy, MD, from Charité - Universitätsmedizin Berlin > Bernhard Meyer, MD, from Technical University of Munich > Andrew Gogos, MD from St Vincent's Hospital Melbourne > Matthew Gutman, MD from Alfred Health and Cabrini HEALTH > with Ryan Hamer and Uli Mezger stirring up controversy along the way. We’ll also have the newly-launched inomed stereotactic ultralight system (SUSy) on display. Come and say hello 🧠⚡️
-
Nexstim julkaisi tämän uudelleen
Controversies in Neurosurgery is a fantastic meeting, and we’re very fortunate to have a dedicated Nexstim nTMS tractography workshop with Brainlab that includes live demonstrations of non-invasive motor and language mapping, case presentations from local and international experts, and preliminary research findings from Australian-first nTMS studies. If that doesn’t interest you there’s an exceptionally good program of important (& controversial) discussions relating to best practice in spinal, vascular and neuro-oncology surgery. 📅 Conference: November 13-15, 2024 🕒 Workshop: November 14, 4-6pm 📍The Langham Hotel, Melbourne, Australia Register here: https://lnkd.in/dF3hRqcd
-
A quick reminder for all those interested in preprocedural brain mapping with nTMS combined with IONM. This course is a great opportunity to learn from experts in the field! 👇
🚀 Unlock the Future of Neurosurgery with Cutting-Edge IONM & Brain Mapping Techniques! 🚀 Ready to elevate your practice and ensure every patient receives the best possible care? Join us at the IONM & Brain Mapping Course in London and dive into the latest innovations transforming neurosurgery. This is Part 1 of our new series #ARKANASpotlight where we present our expert speakers and give exclusive insights into their talks! Prof. Sandro Krieg will be sharing insights on “Innovation in Brain Mapping applied to Neurosurgery,” where you’ll learn how advanced techniques and interdisciplinary collaboration are reshaping the field. From visualizing risks to maximizing tumor resection, this course is your gateway to mastering patient-centered care. 💡 Why Attend? Gain hands-on experience with the newest brain mapping technologies. Enhance your preoperative planning with strategies that preserve critical brain functions. Engage in interdisciplinary discussions and real-world case studies. 📅 Don’t miss out—Join us in London and be part of the ARKANA Learning #Community! 👉Book now and profit from the Early Bird price! https://buff.ly/3Xg6FJ9 #ArkanaForum #MedicalEducation #London #IONM
-
This recent publication out of MD Anderson Cancer Center highlights the benefit of integrating nTMS data into radiosurgery treatment planning. In closed-head procedures, like radiosurgery, intraoperative brain mapping isn’t an option. To minimize radiation to critical structures, clinicians can use functional brain mapping to guide treatment planning – shifting the weights of the isobeams away from regions that control critical brain function. Unlike standard anatomically-seeded DTI, nTMS and nTMS-seeded DTI uniquely capture function regardless of any lesion-induces functional re-organization. In this study, researchers compared the clinical utility of using nTMS and nTMS-seeded DTI compared to standard anatomically-seeded DTI to guide treatment planning. nTMS testing in the radiation oncology clinic met criteria for feasibility. Results demonstrated that the maximum dose (Dmax) to the nTMS-seeded motor tracts correlated with magnitude of negative impact in motor function and overall quality of life. The notable differences in location and size of the nTMS-seeded motor tracts compared to the anatomically-seeded motor tracts suggest that nTMS may improve motor tract delineation to inform clinical decision making and stereotactic radiosurgery treatment planning. To read the full publication: https://lnkd.in/evJNVEfx #nTMS #radiosurgery #dti #brainmapping
-
Nexstim julkaisi tämän uudelleen
A big thank you to all participants and speakers of this year’s 13th nTMS Symposium, held in Berlin this week! Great to hear from so many professionals in different fields, advancing the use of nTMS together! #ntms #neuromodulation #neurosurgery #nTMSsymposium
-
A big thank you to all participants and speakers of this year’s 13th nTMS Symposium, held in Berlin this week! Great to hear from so many professionals in different fields, advancing the use of nTMS together! #ntms #neuromodulation #neurosurgery #nTMSsymposium
Samankaltaisia sivuja
Rahoitus
Viimeinen kierros
Listautumisannin jälkeinen velka1 605 667,00 $
Sijoittajat
Finnvera Venture Capital